DoD awards $30.9M contract for 340M pipette tips monthly, boosting CONUS production capacity

Contract Overview

Contract Amount: $30,932,750 ($30.9M)

Contractor: Mettler-Toledo Rainin, LLC

Awarding Agency: Department of Defense

Start Date: 2021-09-10

End Date: 2023-12-31

Contract Duration: 842 days

Daily Burn Rate: $36.7K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 1

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: COVID-19 DHHS CAPACITY EXPANSION TO INCREASE CONUS PRODUCTION OF PIPETTE TIPS - ACTION AWARDED UNDER CSO FA8119-21-S-C001. CONTRACT WILL RESULT IN CAPACITY TO PRODUCE 340 MILLION PIPETTE TIPS PER MONTH.

Place of Performance

Location: OAKLAND, ALAMEDA County, CALIFORNIA, 94621

State: California Government Spending

Plain-Language Summary

Department of Defense obligated $30.9 million to METTLER-TOLEDO RAININ, LLC for work described as: COVID-19 DHHS CAPACITY EXPANSION TO INCREASE CONUS PRODUCTION OF PIPETTE TIPS - ACTION AWARDED UNDER CSO FA8119-21-S-C001. CONTRACT WILL RESULT IN CAPACITY TO PRODUCE 340 MILLION PIPETTE TIPS PER MONTH. Key points: 1. Contract aims to significantly increase domestic production of essential medical supplies. 2. Awarded under a specific Other Transaction Authority (OTA) agreement, suggesting a non-traditional procurement path. 3. The fixed-price nature of the contract provides cost certainty for the government. 4. Long duration of 842 days indicates a sustained need for increased capacity. 5. Focus on capacity expansion rather than immediate delivery of goods. 6. Geographic concentration of awardee in California may have regional economic implications.

Value Assessment

Rating: good

The contract value of $30.9 million is for capacity expansion, not a direct purchase of goods. Benchmarking is difficult without knowing the specific terms of the OTA and the cost of establishing new production lines. However, the goal of producing 340 million pipette tips per month suggests a significant scale, and the fixed-price structure implies that the contractor bears the risk of cost overruns in establishing this capacity. Further analysis would require understanding the unit cost of production once capacity is achieved and comparing it to existing market prices for similar volumes.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, indicating that multiple vendors had the opportunity to bid. This competitive process is generally expected to yield better pricing and terms for the government. The specific OTA (CSO FA8119-21-S-C001) under which it was awarded might have its own unique solicitation and evaluation processes, but the 'full and open' designation suggests a broad outreach.

Taxpayer Impact: Full and open competition is favorable for taxpayers as it drives down costs through market forces, ensuring the government receives the best value for its investment in critical supply chain resilience.

Public Impact

Increases domestic manufacturing capacity for critical medical supplies (pipette tips). Enhances the U.S. Continental (CONUS) supply chain resilience for healthcare and research sectors. Supports the healthcare and life sciences industries by ensuring availability of essential consumables. Potential for job creation in California where the contractor is located. Reduces reliance on foreign manufacturing for a key medical component.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Potential for long-term reliance on a single vendor for expanded capacity if follow-on orders are placed.
The effectiveness of the capacity expansion will depend on the contractor's ability to meet production targets.
The specific OTA used might limit transparency compared to traditional FAR-based contracts.
The contract focuses on capacity, not immediate supply, so actual availability of tips is not guaranteed by this award alone.

Positive Signals

Addresses a critical need for domestic production of medical supplies.
Awarded through a competitive process, suggesting potential for value.
Fixed-price contract provides cost certainty for the government.
Long-term award indicates a strategic investment in supply chain security.

Sector Analysis

This contract falls within the Medical Equipment and Supplies Manufacturing sector, specifically focusing on surgical appliances and supplies. The U.S. market for medical consumables is substantial, driven by healthcare providers, research institutions, and diagnostic laboratories. This award represents a strategic investment by the Department of Defense to bolster domestic production capabilities, likely in response to lessons learned during recent public health crises where supply chain vulnerabilities were exposed. Comparable spending benchmarks are difficult to establish for capacity expansion contracts under OTAs, but the scale of 340 million tips per month indicates a significant market share or a substantial increase in overall domestic capacity.

Small Business Impact

The contract was not set aside for small businesses, and the awardee, METTLER-TOLEDO RAININ, LLC, is a large business. There is no explicit mention of subcontracting requirements for small businesses within the provided data. This award does not appear to directly benefit the small business ecosystem through set-asides, though the increased domestic capacity could indirectly support smaller entities within the broader healthcare supply chain.

Oversight & Accountability

The contract is awarded under a CSO OTA, which may have different oversight mechanisms than traditional Federal Acquisition Regulation (FAR) contracts. The Department of the Air Force, as the issuing agency, would typically have program management and oversight responsibilities. Transparency may be enhanced or reduced depending on the specific terms of the OTA and reporting requirements. Inspector General jurisdiction would likely apply to ensure proper use of funds.

Related Government Programs

COVID-19 related medical supply chain initiatives
Domestic manufacturing capacity expansion programs
Medical consumables procurement
Defense Production Act initiatives

Risk Flags

Reliance on Other Transaction Authority (OTA) may reduce transparency.
Contract is for capacity expansion, not immediate delivery of goods.
Potential for long-term dependence on contractor if follow-on orders are placed.
Geographic concentration of awardee.

Frequently Asked Questions

What is this federal contract paying for?

Department of Defense awarded $30.9 million to METTLER-TOLEDO RAININ, LLC. COVID-19 DHHS CAPACITY EXPANSION TO INCREASE CONUS PRODUCTION OF PIPETTE TIPS - ACTION AWARDED UNDER CSO FA8119-21-S-C001. CONTRACT WILL RESULT IN CAPACITY TO PRODUCE 340 MILLION PIPETTE TIPS PER MONTH.

Who is the contractor on this award?

The obligated recipient is METTLER-TOLEDO RAININ, LLC.

Which agency awarded this contract?

Awarding agency: Department of Defense (Department of the Air Force).

What is the total obligated amount?

The obligated amount is $30.9 million.

What is the period of performance?

Start: 2021-09-10. End: 2023-12-31.

What is the specific Other Transaction Authority (OTA) agreement used for this award, and what are its implications for competition and oversight?

The contract was awarded under CSO FA8119-21-S-C001, identified as an Other Transaction Authority (OTA). OTAs are acquisition instruments authorized by statute that allow the government to enter into agreements other than traditional contracts, grants, or cooperative agreements. They are often used to rapidly prototype, develop, or produce technologies and capabilities, particularly in areas of national defense and emerging technologies. The implications for competition can vary; while this specific award states 'full and open competition,' other OTAs might be structured for non-competitive awards or have different solicitation processes. Oversight under OTAs can sometimes be less stringent or transparent than under traditional FAR-based contracts, as they are not always subject to the same reporting and administrative requirements. However, they offer flexibility in terms of requirements, cost principles, and intellectual property rights, which can accelerate development and production.

How does the projected monthly production capacity of 340 million pipette tips compare to current domestic or global market supply?

The projected capacity of 340 million pipette tips per month represents a significant increase in domestic production. While precise figures for current global and domestic market supply are not readily available in the public domain, the fact that the Department of Defense is investing in expanding this capacity suggests a perceived gap or vulnerability in the existing supply chain. Pipette tips are essential consumables in laboratories for research, diagnostics, and clinical testing. During periods of high demand, such as a pandemic, shortages can occur. This award aims to build resilience by substantially boosting the ability to produce these items domestically, potentially making the U.S. less reliant on international sources and better prepared for future surges in demand.

What is the track record of Mettler-Toledo Rainin, LLC in fulfilling government contracts, particularly for medical supplies or manufacturing capacity?

Mettler-Toledo Rainin, LLC is a well-established entity in the life sciences industry, known for its pipettes and related consumables. While specific details of their past government contract performance are not provided in this data snippet, their selection for a significant capacity expansion award suggests a level of confidence from the Department of Defense in their capabilities. Companies of this nature often have experience supplying large commercial and institutional customers, which can translate to government contract fulfillment. A deeper analysis would involve reviewing the Federal Procurement Data System (FPDS) for their contract history, including performance ratings, past performance evaluations, and any reported issues or successes on previous awards to assess their reliability and experience with government requirements.

What are the potential risks associated with awarding a contract for capacity expansion versus direct procurement of goods?

The primary risk with awarding a contract for capacity expansion, as seen here, is that it represents an investment in infrastructure and capability rather than an immediate acquisition of goods. The government bears the upfront cost of establishing this capacity, and there is a risk that the projected demand may not materialize, or that the contractor may not be able to achieve the targeted production levels efficiently or cost-effectively. Unlike direct procurement where goods are delivered upon completion, capacity expansion requires subsequent orders to realize the benefit of the built capacity. There's also a risk that the technology or market needs could shift, making the expanded capacity less relevant. However, the benefit is enhanced supply chain resilience and the potential for lower unit costs once production is scaled.

How does this $30.9 million investment in pipette tip capacity align with broader federal strategies for strengthening domestic medical supply chains?

This contract directly aligns with broader federal strategies aimed at strengthening domestic medical supply chains, particularly those highlighted during the COVID-19 pandemic. Initiatives under the Defense Production Act (DPA) and other programs have focused on onshore manufacturing of critical goods, reducing reliance on foreign sources, and building surge capacity. By investing in the capacity to produce 340 million pipette tips monthly, the Department of Defense is taking a proactive step to ensure the availability of essential laboratory consumables. This supports national security by mitigating supply chain vulnerabilities and enhances public health preparedness. It reflects a strategic shift towards ensuring that the U.S. has the domestic industrial base necessary to respond effectively to future health crises or other emergencies.

Industry Classification

NAICS: Manufacturing › Medical Equipment and Supplies Manufacturing › Surgical Appliance and Supplies Manufacturing

Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Solicitation ID: FA811921SC001

Offers Received: 1

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Parent Company: Mettler-Toledo International Inc.

Address: 7500 EDGEWATER DR, OAKLAND, CA, 94621

Business Categories: Category Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $30,932,750

Exercised Options: $30,932,750

Current Obligation: $30,932,750

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Cost or Pricing Data: NO

Timeline